Search results
Earnings call: Verona Pharma reports Q1 2024 results, eyes COPD market By Investing.com
Investing.com· 5 days agoVerona Pharma (NASDAQ:VRNA) has announced its first quarter 2024 financial results, highlighting the...
Verona Pharma Reports First Quarter 2024 Financial Results and Provides Corporate Update - Verona...
Benzinga· 6 days agoPDUFA Target Action Date for Ensifentrine of June 26, 2024 Finalizing commercial launch preparations Strong balance sheet supports commercialization and pipeline expansion Conference call today at 9:00 a.m. EDT /
Sanofi to make €1bn biomanufacturing investment in France
Pharmaceutical Technology via Yahoo Finance· 14 hours agoThis will support future biologics and vaccine launches and accommodate the growth of Dupixent - on...
BofA bullish on Apogee stock, sees significant market growth potential By Investing.com
Investing.com· 4 days agoFriday, BofA Securities initiated coverage on Apogee (NASDAQ:APOG) Therapeutics Inc (NASDAQ:APGE)...
The Assistance Fund Opens New Program for Chronic Obstructive Pulmonary Disease
Digital Journal· 1 day agoChronic obstructive pulmonary disease is a chronic lung disease impacting millions of Americans each year. People living with COPD experience difficulty breathing, wheezing ...
Dupixent set for FDA review in adolescent chronic inflammatory sinus disease
Pharmaceutical Technology via Yahoo Finance· 1 day agoDupixent was first approved in 2017 for the treatment of atopic dermatitis, also known as eczema....
Patients Fare Better When They Get Palliative Care Sooner, Not Later
Scientific American· 12 hours agoIn the last months of my mother’s life, before she went into hospice, she was seen at home by a...
Sanofi boosts French biomanufacturing with €1 billion investment
Investing.com· 2 days agoSanofi (EPA: SASY ) (NASDAQ: SNY ), a global biopharmaceutical company, announced today a...
Verona Pharma PLC Reports Q1 2024 Earnings: A Detailed Financial
Guru Focus· 4 days agoThe biopharmaceutical company, which focuses on developing treatments for respiratory diseases, reported a net loss and detailed its strategic preparations for the anticipated ...
Theravance Biopharma to Participate in an Upcoming Investor Conference
WKRN Nashville· 6 days agoTheravance Biopharma, Inc. (NASDAQ: TBPH) will participate in a Fireside Chat at the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ Monday, May 20 at 11:30 AM EDT (8:30 ...